Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
ASSETS
CURRENT ASSETS:
Cash
Investments
Accounts receivable, net of allowance for credit losses of $214,444 and $150,300 at September 30, 2024 and December 31, 2023, respectively
Inventory, net
Prepaid expenses
Current assets of discontinued operations
Current portion of note receivable
Total Current Assets
Operating lease right-of-use assets
Property, plant and equipment, net
Other assets
Related party note receivable, non-current
Note receivable, non-current
Non-marketable equity investment in subsidiary
Non-current assets of discontinued operations
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
Accounts payable - related parties
Accrued expenses and other current liabilities
Customer deposits
Current portion of notes payable
Nonrelated Party
Related Party
Total current portion of notes payable
Current portion of finance leases
Advances from related parties
Current portion of operating lease liabilities
Contract liabilities
Current liabilities of discontinued operations
Total Current Liabilities
Notes Payable - related parties
Nonrelated Party
Related Party
Total notes Payable - related parties
Finance leases, net of current portion
Operating lease liabilities, net of current portion
Non-current liabilities of discontinued operations
Total Liabilities
STOCKHOLDERS’ EQUITY:
 Common stock: $0.0001 par value, 30,000,000 shares authorized; 14,408,674 and 13,425,342 issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Total  Common stock: $0.0001 par value, 30,000,000 shares authorized; 14,408,674 and 13,425,342 issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ (Deficit) Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support